These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28717253)

  • 1. Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability.
    Yusuf MZ; Raslan Z; Atkinson L; Aburima A; Thomas SG; Naseem KM; Calaminus SDJ
    Sci Rep; 2017 Jul; 7(1):5582. PubMed ID: 28717253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of stress fibre formation by Nitric Oxide mediated RhoA inhibition leads to reduction in the height of preformed thrombi.
    Atkinson L; Yusuf MZ; Aburima A; Ahmed Y; Thomas SG; Naseem KM; Calaminus SDJ
    Sci Rep; 2018 Feb; 8(1):3032. PubMed ID: 29445102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K; Faul C; Daiss W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalisation of cAMP-dependent signalling in blood platelets: The role of lipid rafts and actin polymerisation.
    Raslan Z; Naseem KM
    Platelets; 2015; 26(4):349-57. PubMed ID: 24832788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation.
    Coupland CA; Naylor-Adamson L; Booth Z; Price TW; Gil HM; Firth G; Avery M; Ahmed Y; Stasiuk GJ; Calaminus SDJ
    J Thromb Haemost; 2023 Sep; 21(9):2545-2558. PubMed ID: 37210073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.
    Bruckdorfer KR; Buckley S; Hassall DG
    Biochem J; 1984 Oct; 223(1):189-96. PubMed ID: 6093767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhalational anesthetics on alpha2-adrenergic signaling in isolated platelets.
    Pentyala S; Moller D; Chowdhury A; Sung KY; Rebecchi M
    Toxicol Lett; 1998 Nov; 100-101():115-20. PubMed ID: 10049130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.
    Salari H; Duronio V; Howard S; Demos M; Pelech SL
    Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators.
    Grünberg B; Kruse HJ; Negrescu EV; Siess W
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
    Weber DR; Nichols WK; Mohammad SF
    Thromb Res; 1986 May; 42(4):477-87. PubMed ID: 3012821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
    Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
    Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition.
    Siess W; Lapetina EG
    Biochem J; 1990 Nov; 271(3):815-9. PubMed ID: 1700902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
    Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forskolin alters sensitivity of the cAMP-generating system to stimulatory as well as to inhibitory agonists. A study with intact human platelets and guinea pig myometrium.
    Mokhtari A; Do Khac L; Harbon S
    Eur J Biochem; 1988 Sep; 176(1):131-7. PubMed ID: 2843365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin.
    Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI
    Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.